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Background: Tissue hypoperfusion occurs frequently during surgery and may contribute to postoperative organ
dysfunction. There is a need for perioperative treatment protocols aiming at improving tissue oxygenation (StO2).
We hypothesised that intra-operative optimisation of StO2 improves tissue perfusion and thus reduces postoperative
complications. Furthermore, we evaluated the feasibility of the optimisation algorithm used.
Methods: We randomized 50 high-risk patients, all >65 years with ASA physical status III, who underwent major
abdominal surgery under standardized balanced general anesthesia combined with epidural analgesia. Throughout
surgery StO2 was monitored at the thenar eminence using near-infrared spectroscopy. All patients were treated
according to a standard care algorithm. In addition, patients in the intervention group were treated with dobutamine if
necessary to keep or raise StO2 ≥ 80%. Data were recorded continuously and complications were recorded during
hospital stay with a maximum of 28 days.
Results: The number of complications was not significantly different between groups (11 vs 20; p = 0.23). Eleven
patients in the intervention group had no complication, versus 7 in the control group. There was no significant
difference between groups in length of stay in ICU or in hospital. Only ten patients in the intervention group
received dobutamine. Administration of dobutamine resulted in a moderate 6 [−3 to 10] % increase of StO2. The
overall protocol adherence was 94%.
Conclusions: No statistically significant difference in outcome was realized through intraoperative optimization of
StO2 values in this pilot study. The protocol used may be considered feasible for clinical practice. Further research
is obligatory to define both the optimal StO2 threshold and intervention to treat tissue hypoperfusion.
Trial registration: ClinicalTrials.gov identifier: NCT01342900. Registered 21 April 2011.
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Goal-directed therapyBackground
Postoperative complications determine long-term survival
after high-risk surgery. Although high-risk surgical pa-
tients account for a minority of surgical procedures
they represent a vast majority of post-operative mortality
rates [1]. Therefore, a decrease in post-operative com-
plications is important and can be achieved by using
goal-directed fluid optimization [2]. In order to limit
post-operative complications, adequate monitoring and
optimisation of physiological variables during surgery are
necessary.* Correspondence: p.van.beest@umcg.nl
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unless otherwise stated.Hemodynamic variables such as heart rate, arterial pres-
sure and central venous pressure are commonly used but
have been proven to be poor predictors of outcome. In
contrast, the use of flow-related variables such as cardiac
index (CI), oxygen delivery (DO2) and central venous oxy-
gen saturation (ScvO2) have been associated with im-
proved outcome after high-risk surgery [3]. Improvement
of these hemodynamic and oxygen derived variables may
affect tissue oxygenation and as a result preserve organ
function. While these variables reflect global changes in
either the upstream or the downstream part of the circula-
tion and not regional changes as tissue oxygenation, they
may be of vital importance since undetected tissue hyp-
oxia may contribute to postoperative organ dysfunction.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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quently during high-risk surgery or in high-risk patients
undergoing surgery [4,5] there is a lack of protocols for
the perioperative management of high-risk surgical pa-
tients [6].
The purpose of the present interventional pilot study
is primarily to evaluate the effect of the use of a protocol
based on optimisation of tissue oxygenation (StO2) on
the incidence of perioperative complications. As a sec-
ondary objective, we assessed the feasibility of such opti-
misation protocol in clinical practice.
Methods
The study complied with the Declaration of Helsinki.
The protocol was approved by the Local Ethics Committee
(Medisch Ethische Toetsingscommissie UMC Groningen;
METc 2010/209) and the study was registered on Clinical-
Trials.gov (NCT01342900). Written informed consent was
obtained from all participants during the pre-anesthetic
consultation.
Patients
Eligible patients were ASA III and IV patients of 65 years
and older who were scheduled to undergo elective major
surgery under general anesthesia combined with epidural
analgesia.
Exclusion criteria were patients undergoing emergency
surgery, refusal, neurosurgical patients, and patients with
disseminated malignancy or receiving palliative treat-
ment only. Patients undergoing extensive liver surgery
requiring low central venous pressure (CVP) manage-
ment and patients scheduled for a fast track protocol
were excluded as well.
Anesthetic technique
The patients received a standardized balanced anesthesia.
Each patient received acetaminophen 1000 mg orally as
premedication. Standard vital signs monitors were placed,
including Bispectral monitoring [BIS, Aspect Medical
Systems, Norwood, USA]. Thoracic epidural catheter
was placed by standard procedure. Anesthesia was in-
duced using target-controlled infusion (TCI) of sufentanil
with an effect site concentration (Cet) of 15 ng ml
−1 and
TCI of propofol (2–4 μg ml−1 Cet) according to institu-
tional practice, adjusted if necessary to keep BIS in the
range of 40–60. After loss of verbal contact and con-
firmation of adequate mask ventilation, rocuronium
(0.6 mg kg−1) was administered and the patient’s trachea
was intubated. Patients were mechanically ventilated
(volume controlled mode) with a tidal volume of 7 ml kg−1
body weight, unless required otherwise, i.e. one lung venti-
lation during oesophagotectomy. Subsequently, TCI sufen-
tanil was reduced to 0.10 ng ml−1 Cet. A bolus of 6–8 ml
0.25% levobupivacaine and 20–30 μg sufentanil was givenepidurally before start of surgery, and at skin incision
sufentanil was increased to 0.20 ng ml−1 Cet. Epidural an-
algesia with 0.125% levobupivacaine + 1 μg ml−1 sufentanil
was maintained at a rate of 6–8 ml h−1. A radial or bra-
chial arteria was cannulated for continuous measurement
of the arterial pressure and was connected to the FloTrac
Vigileo system (Version 03.02; Edwards Lifesciences
LLC, Irvine, CA, USA) for measuring cardiac output
(CO). All patients received a central venous line (jugular
vein) with continuous oximetry (PreSep catheter; Edwards
Lifesciences LLC, Irvine, CA, USA) for measuring ScvO2.
Study protocol
StO2 was monitored non-invasively in all patients by
near infrared spectroscopy using the InSpectra System
[Model 650; Hutchinson Technology, Hutchinson, MN,
USA]. The device consists of a monitor and a sensor,
which is placed on the thenar eminescence of the pa-
tient. In the control group the anesthetist/investigator
was blinded for data from the InSpectra monitor. All pa-
tients were treated according to the standard care algo-
rithm (Figure 1). No dobutamine was to be administered
in the control group. In addition, patients in the inter-
vention group were treated according to the intervention
algorithm aiming to keep or raise the StO2 ≥ 80% (Figure 1).
If the patient’s heart rate exceeded 110 beats per minute
or if new rhythm disturbances occurred during dobuta-
mine infusion it was left to the anesthesist’s discretion not
to give or not to increase dobutamine.
Randomisation
After induction of anesthesia, but prior to the start of
the surgery, patients were randomly assigned to the control
group or the intervention group using sealed envelopes.
Follow-up
Upfront, all patients were scheduled to be postopera-
tively monitored either at an intensive care unit (ICU)
or at a prolonged stay at the post-anesthesia care unit
(PACU). All PACU and ICU teams were blinded for
patients’ allocation. Follow-up for postoperative com-
plications continued during the total hospital stay with
a maximum of 28 days.
Data collection
All standard data from the anesthesia monitor (MP70,
Philips, Eindhoven, NL) was recorded continuously (sam-
pling rate of 1 Hz) utilizing data-logging software (RugLoop
II, Demed Engineering, Temse, Belgium) on a medical
grade Windows XP based personal computer. The StO2
data of the InSpectra™ device and the hemodynamic vari-
ables were imported into Microsoft Excel 2010® (Microsoft,
Redmond, WA, USA) for synchronisation and analysis.
After graphical representation, a visual inspection of the
Figure 1 Standard care and intervention algorithm.MAP, mean arterial pressure; CVP, central venous pressure; Hb, hemoglobin; StO2, tissue oxygenation.
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caused by artifacts. Next, a 30-second moving median
with 15-second steps was calculated for all studied vari-
ables. The evolution of the absolute values was plotted
from 10 minutes before the start of dobutamine adminis-
tration until 45 minutes thereafter.
All commonly used variables were recorded, including
ventilator settings. In addition, patient characteristics,
surgical information, fluid administration, and use of
inotropes were collected. To prevent a ruffled picture
on length of stay numbers due to the logistic reality of
the PACU or the ICU, ‘fit for discharge’ criteria were
noted every 6 hours during PACU/ICU stay. These cri-
teria were: spontaneous breathing, oxygen saturation
(SpO2) > 92% with < 3 litre O2/minute, systolic arterial
pressure > 100 mm Hg without vasoactive or inotropic
support, and temperature in range of 36–38.5°C. The
patients were considered fit for discharge when all cri-
teria were fulfilled. Both the therapeutic intervention
scoring system (TISS)-score and sequential organ failure
assessment (SOFA)-score were noted for insight in re-
source utilization and the degree of organ failure.
Statistical analysis
A priori, the population was divided into two groups:
control group vs. intervention group. In addition, a sub-
group from the intervention group was analyzed, i.e. pa-
tients in whom dobutamine was actually used (Dobu+
subgroup). Two-tailed statistical tests were performed by
the statistical package for the social sciences (IBM SPSS
20 for Windows, Chicago, IL, USA). GraphPad software
(Prism 5.0, La Jolla, CA, USA) was used for graphics. All
continuous data were tested for normal distribution with
the D’Agostino-Pearson omnibus normality test beforeFigure 2 Flowdiagram of the study.further statistical analysis. Differences between groups
were assessed using Student’s t-test or Wilcoxon-Mann–
Whitney test where appropriate. For categorical data
Chi-Square test or Fisher’s exact test was applied. Statis-
tical significance was assumed at p < 0.05. Non-parametric
data are presented as median [quartiles]. G Power was
used to calculate a sample size from differences in the
number of post-operative complications between the two
study groups [7].Results
Patient characteristics
A total of fifty patients were included and randomized of
whom ten patients had to be excluded from the study.
The reasons for exclusion were protocol deviation (n = 2;
poor use of equipment), protocol violation (n = 1; use of
dobutamine in control group), meeting exclusion criteria
peri-operatively (n = 7; disseminated malignancy or unable
to place epidural catheter). As a result, forty patients were
included for analysis (Figure 2).
Table 1 displays patient characteristics and intraopera-
tive characteristics. Comorbidities were similar in both
groups. All patients were scored grade III ASA physical
status classification. No significant differences between
the two groups with respect to type of surgery and adminis-
tered fluids during surgery were noticed.Tissue oxygenation
Baseline StO2 was 85 [82–90]% in all patients. In the
control group (n = 20) the median StO2 value was 83
[77–87]%. In eleven of these cases StO2 values showed a
decline below the threshold of 80%. Median StO2 values
were < 80% in seven patients in the control group.
Table 1 Patient baseline and intraoperative characteristics (n = 40)
Characteristics Control (n = 20) Intervention (n = 20) P-value* Dobu+ (n = 10) P-value§
Age (yr) 75 [69–78] 71 [69–78] 71 [69–81]
Gender (M/F) 16/4 16/4 9/1
Body Mass Index (m/kg2) 27 [22–31] 25 [23-27] 25 [23–28]
Smoking status (%) 60 35 40
Medical history (n)
COPD 4 4 1
CAD 5 9 5
CHF 5 3 2
IDDM 3 6 3
TIA 2 2 1
Hemoglobine (g/dl) 12.2 [10.6-14.5] 13.7 [12.6-15.3] 0.34 13.4 [10.6-15.6] 0.25
Type of surgery (n) 0.18 0.13
AAA 9 5 2
Oesophagus 1 2 2
Stomach 1 3 1
Pancreas 1 5 4
Colon 3 2 0
Other 5 3 1
Duration surgery (min) 277 [221–334] 262 [145–387] 0.63 349 [246–500] 0.35
Blood loss (ml) 800 [350–1575] 375 [200–950] 0.07 550 [288–1050] 0.22
RBC transfusion (ml) 0 [0–300] 0 [0–0] 0.06 0 [0–150] 0.32
Colloids (ml) 1000 [563–1000] 500 [0–1500] 0.40 1000 [500–1625] 0.83
Crystalloids (ml) 3000 [2350–3875] 2725 [2075–3500] 0.80 3400 [2500–4125] 0.57
Norepinephrine (%) 50 75 90
Hemoglobine (g/dl) 10.8 [9.2-12.6] 10.9 [9.9-12.3] 0.73 11.4 [9.3-12.4] 0.74
StO2 - baseline (%) 86 [83–90] 86 [81–90] 0.68 81 [78–84] 0.01
StO2 - average (%) 83 [77–87] 85 [78–91] 0.45 78 [74–82] 0.07
StO2 - minimum (%) 71 [59–79] 76 [70–82] 0.22 70 [57–72] 0.40
ScvO2 - baseline (%) 80 [70–85] 81 [75–84] 0.91 75 [74–83] 0.53
ScvO2 - average (%) 77 [70–81] 81 [77–83] 0.09 78 [72–83] 0.35
ScvO2 - minimum (%) 61 [55–68] 70 [59–72] 0.13 65 [57–72] 0.38
Dobu +, subgroup of intervention subjects that did receive dobutamine; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CHF, chronic
heart failure; IDDM, insulin dependent diabetes mellitus; TIA, transient ischemic attack; AAA, abdominal aortic aneurysm; RBC, red blood cell; StO2, tissue
oxygenation; ScvO2, central venous oxygen saturation; baseline: start surgery; *Control versus Intervention;
§ Control versus Dobu+.
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ative StO2 values of the control group and intervention
group (83 [77–86.5]% vs. 82.5 [78–90]%; p = 0.83). In half
of the patients randomized for the intervention group
StO2 values showed a drop below the predefined thresh-
old of 80%. Based on the study protocol dobutamine
was administrered in those ten cases (Dobu+ subgroup;
Table 1). Maximum median dobutamine dose was 4.9
[4.3-7.0] μg kg−1 min−1. The predefined maximum dose
of 12.5 μg kg−1 min−1 was never reached. In one case
dobutamine dosage was limited (10 μg kg−1 min−1) since
elevation in heart rate was considered too high (>100beats per minute) by the attending anesthesist. Figure 3
shows the graphs of the continuously measured StO2
values in the Dobu+ subgroup. Dobutamine induced a 6
[−3 to 10]% increase in StO2, a 0.3 [0.0-0.6] litre min
−1 m−2
increase in CI, and a 4 [0 to 7]% increase in ScvO2
(Figure 3).
In the control group 9 patients (3/9 aorta surgery)
received red blood cell (RBC) transfusions (range 300–
3400 ml). Three patients from the intervention group
(3/3 aorta surgery) received RBC transfusions (range
600–1800 ml). Two patients in the Dobu+ subgroup re-
ceived 600 ml RBC transfusions. There was no significant
Figure 3 Evolution of the individual patient values (thin lines) and the average values (thick line) of the tissue oxygenation (StO2) and
the relative change of both cardiac index (CI), delta CI, and central venous oxygen saturation (ScvO2), delta ScvO2 (data of two
patients missing/inadequate due to technical problems). All graphs are synchronized at the moment of the first dobutamine administration
(Time = 0; arrow). Values are shown from 10 minutes before dobutamine administration until 45 minutes thereafter.
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transfused (p = 0.06 and p = 0.32, respectively), in number
of patients who received RBC transfusions (p = 0.08 and
p = 0.25, respectively) or in post transfusion hemoglobine
values (p = 0.73 and p = 0.74, respectively); Table 1.Outcome data
Neither the total amount of complications nor the distri-
bution of complications showed significant differences
between groups (Table 2). Eleven patients in the inter-
vention group had no complication, versus 7 in the con-
trol group (p = 0.20). Also, the median length of stay in
various wards and hospital stay were equally distributed.
One patient randomized to the intervention group died
within 28 days postoperatively due to bowel ischemia
noted during relaparotomy. One relaparotomy in the con-
trol group revealed leakage after pancreatic surgery.
Based on the average number of postoperative compli-
cations between the control and intervention group, a
sample size was calculated revealing at least 118 patients(59 per group) will be needed to gain significant results
in a follow-up study, with a power of 0.80.Feasibility
The overall protocol adherence was 96% in the control
group and 92% in the intervention group (Figure 2).
Protocol adherence was determined by assessing the pro-
portion of patients that had to be excluded due to protocol
violation and deviation and consequently assessing the
number of cases where the protocol was successfully
followed. The total exclusion amounted to 20% (17% from
the control group and 23% from the intervention group)
but exclusion due to protocol deviation or violation was
only 6%.Discussion
During (high-risk) surgery or during treatment of critic-
ally ill patients, the ultimate goal is to maintain or to re-
store sufficient StO2 since it is a prerequisite of aerobic
metabolism. In recent years the clinical use of near
Table 2 Postoperative outcome
Control (n = 20) Intervention (n = 20) P-value* Dobu+ (n = 10) P-value§
Number of complications (n) 20 11 0.23 7 0.49
Patients without complications (n) 7 11 0.34 4 1.00
Complications 0.35 0.56
Pneumonia 4 5 3
Respiratory failure 1
Cardiac failure 1 1
Supraventricular arrhythmia 3 1
Relaparotomy 1 1 1
Ileus 3 1 1
Urinary tract infection 2 1 1
Renal failure 1
TIA 1
Delirium 4
Hematoma 1
Death 1
SOFA score 5 [2-12] 6 [5-11] 0.73 5 [5-9] 0.78
TISS score 25 [21–33] 26 [22–30] 0.95 28 [26–48] 0.96
LOS ICU (hours) 22 [21–45] (n = 15) 22 [17–38] (n = 15) 0.53 22 [17–43] (n = 8) 0.50
LOS PACU (hours) 18 [17-22] (n = 5) 18 [13-22] (n = 5) 0.75 17 [17,18] (n = 2) 0.42
LOS FFD (hours) 18 [8–37] 17 [6-23] 0.39 18 [13–36] 0.70
LOS Hosp (days) 12 [9-17] 13 [7-17] 0.96 15 [8-25] 0.72
Dobu+, subgroup of intervention subjects that did receive dobutamine; SOFA, sequential organ failure assessment; TIA, transient ischemic attack;
LOS, length of stay; ICU, intensive care unit; PACU, post anesthesia care unit; FFD, fit for discharge; Hosp, hospital; *Control versus Intervention;
§ Control versus Dobu+.
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ation has increased, especially in the monitoring of crit-
ically ill patients and during cardiac surgery [8-10]. Data
on the intraoperative use of StO2 in non-cardiac surgery
however are scarce. Of note, the study designs differ
substantially, which hampers proper comparison of the
results. A randomised controlled trial excecuted in a
critical care unit showed that postoperative application
of stroke volume guided therapy and low-dose inotropic
therapy (dopexamine) was associated with improved tis-
sue oxygenation [11]. However, due to study design and
insufficient power the investigators were unable to dem-
onstrate an intervention-related reduction in complica-
tions rates. Other recent observations revealed that
minimum StO2 values in the perioperative setting are
inversely associated with outcome [4]. These findings
suggest that perioperative optimisation of StO2 values
may result in better outcome. The present results can-
not fully confirm the abovementioned studies. Despite
the category of patients randomised here (all ASA III,
age > 65 yr) who are at elevated risk for lower StO2
values [12] and perioperative morbidity [13] a signifi-
cant reduction in the number of complications in theintervention group could not be demonstrated in this
pilot study. The relatively small number of patients is
probably the main reason for this. Another important
factor is the fact that only half of the patients random-
ized for the intervention group actually required dobu-
tamine. Also, in only 40% of the patients who received
dobutamine the predefined StO2 threshold of 80% was
reached permanently. One could argue if dobutamine
administration was the most favorable intervention. The
increase in myocardial contractility (β1 adrenoceptors)
and peripheral vasodilation (β2 adrenoceptors) gener-
ated a modest increase in StO2, CI and ScvO2.
Our observations raise another relevant issue, namely
the adequacy of the predefined StO2 threshold of 80%
used in this study. StO2 values below 80% are considered
inadequate [10,14] and together with recommendations
of the manufacturer a threshold of 80% seemed reason-
able. However, in patients scheduled for non-cardiac sur-
gery, the time averaged StO2 values of approximately
85% have been described [4,12]. These StO2 values are
comparable to values seen in healthy volunteers breath-
ing roomair [14,15]. Hence, the StO2 threshold used in
the present study may have been insufficient and the use
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cations in the intervention group. Abovementioned stud-
ies did not describe an optimal StO2 target and therefore
another StO2 threshold than 80%, i.e. 85%, may be consid-
ered for future studies. Of note, flipside to that coin may
be increased use of fluids and vasoactive medication.
We observed a trend of an increased number of RBC
transfusion and of more patients in whom RBC transfu-
sion were conducted in the control group compared to
the intervention group. Although RBC transfusions were
not controlled by study protocol other than a transfusion
threshold of Hb = 5.0 mmol/L we doubt if the transfu-
sions conducted were of influence on our results. Surely,
the effect of RBC transfusions on tissue oxygenation by
increasing oxygen delivery is yet unclear [16,17]. RBC
transfusions elevate the hemoglobin content in the
microcirculation but not necessarily the microcircula-
tory perfusion in cardiac surgery patients [18]. How-
ever, considerable interindividual variability exists and
the effects of RBC transfusion on StO2 values seem un-
predictable [19,20].
A yet unraveled issue with application of NIRS is the
choice of measurement site [21]. For the measurement
of peripheral tissue oxygenation multiple measurement
sites are available. However, only few sites including the
thenar eminence are established [10]. The thenar emi-
nence has a relatively thin fat layer with only minor
inter-individual variation. Also, the thenar eminence par-
ticipates in systemic edema formation to a lesser extent
than other skin regions [22] Abovementioned arguments
together with the practical perspective from an anesthesists
viewpoint explain our choice for the thenar eminence as
measurement site. Nevertheless, in general we suspect that
StO2 measurements mostly convey information on micro-
circulatory integrity. It is possible that only after a persist-
ing and sufficiently large change in systemic oxygen
balance is reflected in thenar StO2. The main research
question is whether the goal-directed StO2 based treat-
ment is correct and well dosed. Based on the present
study we are unable to answer that question.
The development of a feasible protocol to determine
any significant differences between the study groups re-
mains important. For a study as such where small differ-
ences between study groups are observed, it is essential
to accurately collect data. The study protocol should be
clearly outlined for investigators, as to avoid protocol
deviations. We believe that the present study fulfills
these criteria. Data were collected continuously, the at-
tending anesthesists were informed comprehensibly and
the study protocol was present in the operating room at
all times. Studies have shown that protocol adherence
becomes one of the main barriers when implementing
changes in a clinical setting, with regards to goal directed
therapy (GDT) [23-25]. Reasons for low adherence toGDT include time consumption of conducting the proto-
col, the tendency of monitoring to be invasive and per-
sonal disbelief that such a protocol will result in better
outcome [25]. Protocol adherence in this study was 94%
which is considered acceptable (≥75%) [2]. This can be at-
tributed to the convenient and non-invasive nature and
easy interpretation of the obtained data provided by the
NIRS equipment [10].
This study has several limitations. First, the observations
of the present randomized controlled pilot study are lim-
ited to the intraoperative period only. One could argue
that the direct postoperative hours are as interesting in ef-
forts to improve outcome after high-risk surgery. Indeed,
clinically important fluctuations in the balance between
DO2 and VO2 do also occur in the first postoperative
hours [26,27] and corresponding hemodynamic interven-
tions seem appropriate. On top of that, postoperative
hemodynamic optimisation improves tissue oxygenation
[11] and we believe that goal-directed protocols ideally
should also cover the early postoperative period. However,
because of technical challenges in reliably transporting all
the equipment, including the data logging devices, along
with the patient to the ICU or PACU, measurements were
restricted to the intraoperative period. While our results
tend to indicate an advantage of StO2 based goal-directed
therapy, the limited power of this pilot restricts any
clear recommendations before further larger studies are
conducted.
Conclusions
In conclusion, this is the first randomized controlled
study that used StO2 values as a target for hemodynamic
optimization in high-risk abdominal surgery patients.
Our pilot results are inconclusive on the perioperative
optimisation of StO2 values in relation to outcome after
high-risk abdominal surgery. Nevertheless, the peri-
operative strategy described deserves emulation and fur-
ther research is obligatory to define both the optimal
StO2 threshold and intervention to treat or prevent tis-
sue hypoperfusion.
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